- Home
- PLUS vs RCKT Comparison
PLUS vs RCKT Comparison
Compare PLUS & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUS
- RCKT
- Stock Information
- Founded
- PLUS 1990
- RCKT 1999
- Country
- PLUS United States
- RCKT United States
- Employees
- PLUS N/A
- RCKT N/A
- Industry
- PLUS Retail: Computer Software & Peripheral Equipment
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- PLUS Technology
- RCKT Health Care
- Exchange
- PLUS Nasdaq
- RCKT Nasdaq
- Market Cap
- PLUS 1.9B
- RCKT 328.6M
- IPO Year
- PLUS 1996
- RCKT N/A
- Fundamental
- Price
- PLUS $74.47
- RCKT $3.17
- Analyst Decision
- PLUS
- RCKT Buy
- Analyst Count
- PLUS 0
- RCKT 13
- Target Price
- PLUS N/A
- RCKT $12.96
- AVG Volume (30 Days)
- PLUS 160.2K
- RCKT 2.8M
- Earning Date
- PLUS 11-11-2025
- RCKT 11-06-2025
- Dividend Yield
- PLUS 1.33%
- RCKT N/A
- EPS Growth
- PLUS 9.38
- RCKT N/A
- EPS
- PLUS 4.46
- RCKT N/A
- Revenue
- PLUS $2,170,452,000.00
- RCKT N/A
- Revenue This Year
- PLUS $7.12
- RCKT N/A
- Revenue Next Year
- PLUS N/A
- RCKT $108.43
- P/E Ratio
- PLUS $16.87
- RCKT N/A
- Revenue Growth
- PLUS N/A
- RCKT N/A
- 52 Week Low
- PLUS $53.83
- RCKT $2.19
- 52 Week High
- PLUS $106.98
- RCKT $22.00
- Technical
- Relative Strength Index (RSI)
- PLUS 57.53
- RCKT 48.10
- Support Level
- PLUS $73.11
- RCKT $3.09
- Resistance Level
- PLUS $77.50
- RCKT $3.29
- Average True Range (ATR)
- PLUS 2.11
- RCKT 0.15
- MACD
- PLUS 0.22
- RCKT -0.02
- Stochastic Oscillator
- PLUS 64.06
- RCKT 37.94
About PLUS ePlus inc.
ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.